For: | Lynch EN, Campani C, Innocenti T, Dragoni G, Forte P, Galli A. Practical insights into chronic management of hepatic Wilson’s disease. World J Clin Cases 2022; 10(14): 4334-4347 [PMID: 35663095 DOI: 10.12998/wjcc.v10.i14.4334] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i14/4334.htm |
Number | Citing Articles |
1 |
Nikita Sharma, Debashree Debasish Das, Pooja A Chawla. Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease. Health Sciences Review 2023; 6: 100082 doi: 10.1016/j.hsr.2023.100082
|
2 |
Areej Mazhar, Marc S. Piper. Updates on Wilson disease. Clinical Liver Disease 2023; 22(4): 117 doi: 10.1097/CLD.0000000000000079
|
3 |
Yun Mao, Huilan Chen, Weihan Zhu, Shunlan Ni, Shengnan Luo, Shiyue Tang, Zhiyi Chen, Qin Wang, Jinxian Xu, Qi Tu, Haijun Chen, Lujian Zhu. Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease. Journal of Inflammation Research 2025; : 883 doi: 10.2147/JIR.S498340
|
4 |
Fitri Fareez Ramli, Syed Alhafiz Syed Hashim, Betty Raman, Masliza Mahmod, Yusof Kamisah. Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects. Pharmaceuticals 2022; 15(9): 1145 doi: 10.3390/ph15091145
|